SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Tabar L, Fagerberg G, Chen H-S, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. Cancer 1995; 75: 2507.
  • 2
    Tabar L, Dean PB, Duffy SW, Chen HH. A new era in the diagnosis of breast cancer. Surg Oncol Clin North Am 2000; 9: 23377.
  • 3
    Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update in the Swedish Two-County Program of Mammographic Screening for Breast Cancer. Radiol Clin North Am 1992; 30: 187210.
  • 4
    Kopans DB. Breast imaging, 2nd ed. Philadelphia: Lippincott, 1997.
  • 5
    Kopans DB. Updated results of the trials of screening mammography. Surg Oncol Clin North Am 1997; 6: 23363.
  • 6
    Smith RA. Screening fundamentals. J Natl Cancer Inst Monogr 1997; 22: 159.
  • 7
    Michaelson JS, Kopans DB, Cady B. The breast cancer screening interval is important. Cancer 2000; 88: 12824.
  • 8
    Michaelson JS, Satija S, Moore R, Weber G, Garland G, Kopans DB. Properties of the invasive breast cancers seen over the last decade at the Massachusetts General Hospital Breast Imaging Division. Woman Imag (in press).
  • 9
    Norton L. A Gompertzian model of human breast cancer growth. Cancer Res 1988; 48: 706771.
  • 10
    Surbone A, Norton L. Kinetic concepts in the treatment of breast cancer. Ann NY Acad Sci 1993; 698: 4862.
  • 11
    Fournier DV, Weber E, Hoefken W, Bauerm M, Kubli F, Barther V. Growth rate of 147 mammary carcinomas. Cancer 1980; 45: 2198-–207.
  • 12
    Lundgren B. Observations on the growth rate of breast carcinomas and its possible implications for lead time. Cancer 1977; 40: 17225.
  • 13
    Spratt JA, Von Fournier D, Spratt JS, Weber EE. Mammographic assessment of human breast cancer growth and duration. Cancer 1993; 71: 20206.
  • 14
    Spratt JS, Spratt T. Rates of growth of pulmonary metastases and survival. Ann Surg 1964; 159: 16171.
  • 15
    Kuroishi T, Tominaga S, Morimoto T, Tashiro H, Itoh S, Watanabe H, et al. Tumor growth rate and prognosis of breast cancer mainly detected by mass screening. Jpn J Cancer Res 1990; 81: 45462.
  • 16
    Peer PGM, van Dick JAAM, Hendricks JHCL, Holland R, Verbeek ALM. Age-dependent growth of primary breast cancer. Cancer 1993; 71: 354751.
  • 17
    Ulcickas Yood M, McCarthy BD, Lee NC, Jacobsen G, Johnson CC. Patterns and characteristics of repeat mammography among women 50 years and older. Cancer Epidemiol Biomarkers Prev 1999; 8: 5959.
  • 18
    Jepson C, Barudin JL, Weiner JR. Variability in the timing of repeat screening mammography. Prev Med 1997; 26: 4835.
  • 19
    Johnson MM, Hislop TG, Kan L, Coldman AJ, Lai A. Compliance with the screening mammography program of British Columbia: will she return? Can J Public Health 1996; 87: 17680.
  • 20
    Elwood M, McNoe B, Smith T, Bandaranayake M, Doyle TC. Once is enough—why some women do not continue to participate in a breast cancer screening programme. NZ Med J 1998; 111: 1803.
  • 21
    Song L, Fletcher R. Breast cancer rescreening in low-income women. Am J Prev Med 1998; 15: 12833.
  • 22
    Howe HL. Repeat mammography among women over 50 years of age. Am J Prev Med 1992; 8: 1825.
  • 23
    Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000; 92: 10817.
  • 24
    Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996; 276: 338.
  • 25
    Michaelson J. Using information on breast cancer growth, spread, and detectability to find the most effective ways for screening to reduce breast cancer death. Woman Imag 2001; 3: 547.
  • 26
    Blackman DK, Bennett EM, Miller DS. Trends in self-reported use of mammograms (1989–1997) and Papanicolaou tests (1991–1997)—behavioral risk factor surveillance system. MMW 1999; 48: 122.